Medicine Supply Notification: Insulatard® (isophane insulin, human) Penfill® 100units/ml suspension for injection 3ml cartridges
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Insulatard® (isophane insulin, human) Penfill® 100units/ml suspension for injection 3ml cartridges
TO NOTE: This is the second of three MSNs covering discontinuations of Novo Nordisk insulin products (NovoRapid® FlexTouch®, Insulatard® Penfill® and all Levemir® presentations). A third MSN will provide clinical advice on the discontinuation of all Levemir® presentations. Clinicians should not initiate new patients on Levemir® or make any switches from Levemir® to alternative insulins at this time. It should be noted that where alternative insulin products have been recommended, consideration has been made both to these product discontinuations, and availability of other insulin products.
MSN/2024/112
Tier 2 – medium impact
Date of issue: 12th December 2024
- Insulatard® (isophane insulin, human) Penfill® 100units/ml suspension for injection 3ml cartridges are being discontinued; stock is anticipated to be exhausted by June 2025.
- Humulin® I KwikPen® (isophane insulin, human) 100units/ml suspension for injection 3ml pre-filled pens are available and can support a full increase in demand from April 2025.
- Humulin® I (isophane insulin, human) 100units/ml suspension for injection 3ml cartridges are available but cannot support an increase in demand.
A copy of this medicine supply notification, including further information, has been sent to all pharmacy NHS email addresses.
DHSC and NHS England have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
The Tool also details any changes to resupply dates and updates to the entries.
To access the Tool you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.
